Geode Capital Management
ELOX icon

Geode Capital Management’s Eloxx Pharmaceuticals ELOX Stock Holding History

Geode Capital Management’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$305K Buy
+19,946
New +$309K ﹤0.01% 3731

Other funds holding ELOX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Pioneer Family Office
Pioneer Family Office North Miami Beach, Florida $198M AUM 23.66% 1-Year Est. Return
Old Point Trust & Financial Services N A
Old Point Trust & Financial Services N A Newport News, Virginia $341M AUM 20.44% 1-Year Est. Return
Activest Wealth Management
Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Geode Capital Management's ELOX Position: Q3 2026 in Review

Geode Capital Management opened a new position in Eloxx Pharmaceuticals (ELOX) in Q3 2026: 19,946 shares worth $305K. The stake represents ﹤0.01% of the portfolio and ranks #3731 among its holdings.

7 funds tracked by Wall St. Rank hold ELOX as of Q3 2026.

  • Geode Capital Management held 19,946 shares of Eloxx Pharmaceuticals worth $305K as of Q3 2026.
  • Eloxx Pharmaceuticals was a new Geode Capital Management position in Q3 2026.
  • Eloxx Pharmaceuticals made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #3731 holding.
  • 7 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.